HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Melanie Panse Selected Research

Disease Progression

11/2009ABC transporter A3 facilitates lysosomal sequestration of imatinib and modulates susceptibility of chronic myeloid leukemia cell lines to this drug.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Melanie Panse Research Topics

Disease

1T-Cell Lymphoma (Lymphoma, T Cell)
02/2011
1Lymphoma (Lymphomas)
02/2011
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2009
1Disease Progression
11/2009

Drug/Important Bio-Agent (IBA)

1Phosphotransferases (Kinase)IBA
02/2011
1SuspensionsIBA
02/2011
1Sorafenib (BAY 43-9006)FDA Link
02/2011
1Mitogen-Activated Protein Kinase 14IBA
02/2011
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
11/2009
1Pharmaceutical PreparationsIBA
11/2009
1Imatinib Mesylate (Gleevec)FDA Link
11/2009
1bcr-abl Fusion ProteinsIBA
11/2009

Therapy/Procedure

1Withholding Treatment
11/2009
1Therapeutics
11/2009